J Am Pharm Assoc (2003). 2021 Jul-Aug;61(4S):S173-S177. doi: 10.1016/j.japh.2021.01.001. Epub 2021 Feb 19.
Specialty medications may require a prior authorization (PA) before a patient can access the medication. Providers often identify PA approval as a burden for the practice. Pharmacists can facilitate the completion of the PA process.
The primary objective was to evaluate the time to first PA decision (approval or denial) for dermatologic medications dispensed by a community-based specialty pharmacy. A secondary objective was to compare PA timeliness (time to PA approval and time to first medication fill) between a community-based specialty pharmacy and a dermatology provider office.
Realo Specialty Care is a community-based independent specialty pharmacy that provides comprehensive care to patients with complex and chronic conditions such as plaque psoriasis, hidradenitis suppurativa, and atopic dermatitis. Pharmacy services include PA assistance, comprehensive medication management, patient education, and adherence monitoring.
Pharmacy dispensing system data were used to conduct a retrospective analysis of the effectiveness at resolving PA requests. PAs are traditionally completed by a provider's practice, and data are documented within the pharmacy system as a PA task.
Data included PA tasks for dermatology prescriptions for patients aged 18 years or older between January 1, 2017, and June 30, 2019. Initial receipt of the prescription, PA decision, and PA decision date were noted in the PA task and confirmed via fax documentation. The date of first fill was confirmed by prescription data.
The pharmacy completed 677 PA tasks with a mean time to PA decision of 1.9 days, whereas the provider's office averaged 20.9 days (P < 0.001). The pharmacy demonstrated a mean time to first fill of 6.6 days, whereas the provider's office averaged 16.2 days (P < 0.001).
Pharmacies can effectively complete PAs to expedite the filling process for patients and increase medication access. Provider practices could benefit from delegating these tasks to a partnered pharmacy.
专科药物在患者获得药物之前可能需要事先授权（PA）。提供者通常认为 PA 批准是对实践的负担。药剂师可以促进 PA 流程的完成。
主要目的是评估通过社区为基础的专科药房分发的皮肤科药物的首次 PA 决定（批准或拒绝）的时间。次要目的是比较社区为基础的专科药房和皮肤科提供者办公室之间的 PA 及时性（PA 批准时间和首次药物配药时间）。
Realo Specialty Care 是一家社区为基础的独立专科药房，为患有复杂和慢性疾病的患者提供全面的护理，例如斑块状银屑病、化脓性汗腺炎和特应性皮炎。药房服务包括 PA 协助、综合药物管理、患者教育和依从性监测。
药房配药系统数据用于对解决 PA 请求的效果进行回顾性分析。PA 传统上由提供者的实践完成，并且数据在药房系统中作为 PA 任务进行记录。
数据包括 2017 年 1 月 1 日至 2019 年 6 月 30 日期间年龄在 18 岁或以上的皮肤科患者的 PA 任务。在 PA 任务中注意到初始收到处方、PA 决定和 PA 决定日期，并通过传真文件进行确认。首次配药日期通过处方数据确认。
药房完成了 677 项 PA 任务，平均 PA 决定时间为 1.9 天，而提供者办公室的平均时间为 20.9 天（P < 0.001）。药房的首次配药时间平均为 6.6 天，而提供者办公室的平均时间为 16.2 天（P < 0.001）。
药房可以有效地完成 PA，以加快患者的配药过程并增加药物的可获得性。提供者实践可以从将这些任务委托给合作药房中受益。
Zotero 插件